European MSc Molecular Pathology. Personalized medicine presents new opportunities for patients with various diseases. Patient care and safety through tissue and biofluids investigation to the correct diagnosis and subsequent therapy is the mission of Molecular Pathology. However, many patients do not receive the most effective personalized treatments because of challenges associated with integrating predictive biomarker testing into clinical care.

The aim of the Specialised Master® in Biopharmaceutical Management is to prepare future managers of pharmaceutical, medical consulting and biotechnology companies for immediate insertion in a professional environment that is currently undergoing dramatic changes. The programme taught on our Paris campus and London campus offers practical training that combines knowledge acquisition with the development of decision-making skills.

The program covers the bases of molecular and cellular mechanisms driving oncogenesis, the complex cellular and molecular-interacting networks with the tumor microenvironment dictating cancer development and metastatic dissemination, the clinical aspects of cancer pathology, and therapeutic possibilities.

A competitive international Master’s of Public Health in Comparative Effectiveness Research offered in English in Paris by internationally renowned Professors from Europe.